Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of an Uroselective Alpha-1-antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

NCT01568918 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01568918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01568918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of an Uroselective Alpha-1-antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2012
Completion date
November 21, 2019
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative urinary retention